Madrigal Pharmaceuticals Inc. (MDGL) Financial Statements (2026 and earlier)

Company Profile

Business Address 200 BARR HARBOR DRIVE, SUITE 400
WEST CONSHOHOCKEN, PA 19428
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:983,559931,251634,131358,774270,346284,149
Cash and cash equivalent198,693100,01999,915331,54936,26954,004
Short-term investments784,866826,232534,21627,225234,077230,145
Other undisclosed cash, cash equivalents, and short-term investments  5,000    
Restricted cash and investments5,0905,000    
Receivables134,47653,822    
Inventory, net of allowances, customer advances and progress billings74,84134,068    
Inventory74,84134,068    
Other undisclosed current assets47,8048,7863,1502,5951,3381,014
Total current assets:1,245,7701,032,927637,281361,369271,684285,163
Noncurrent Assets
Operating lease, right-of-use asset4,9392,4011,713602797785
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization1,4992,1901,5536018511,047
Intangible asset, including goodwill, after accumulated amortization7,3814,729    
Intangible asset, excluding goodwill, after accumulated amortization7,3814,729    
Other noncurrent assets      
Total noncurrent assets:13,8199,3203,2661,2031,6481,832
TOTAL ASSETS:1,259,5891,042,247640,547362,572273,332286,995
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities309,270168,294118,021115,29276,42846,239
Accounts payable48,87843,59928,04123,83121,3801,017
Accrued liabilities260,392124,69589,98091,46155,04845,222
Other undisclosed current liabilities1,018983527602410318
Total current liabilities:310,288169,277118,548115,89476,83846,557
Noncurrent Liabilities
Long-term debt and lease obligation339,881117,569115,48049,289387468
Long-term debt, excluding current maturities339,881117,569115,48049,289  
Liabilities, other than long-term debt6,7311,0181,186   
Operating lease, liability6,7311,0181,186 387468
Other undisclosed noncurrent liabilities     (387)(468)
Total noncurrent liabilities:346,612118,587116,66649,289387468
Total liabilities:656,900287,864235,214165,18377,22547,025
Equity
Equity, attributable to parent602,689754,383405,333197,389196,107239,970
Common stock222222
Additional paid in capital2,692,2802,556,0951,741,1531,160,079863,495665,385
Accumulated other comprehensive income (loss)873468468(32)(80)47
Accumulated deficit(2,090,466)(1,802,182)(1,336,290)(962,660)(667,310)(425,464)
Total equity:602,689754,383405,333197,389196,107239,970
TOTAL LIABILITIES AND EQUITY:1,259,5891,042,247640,547362,572273,332286,995

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues958,403180,133  273100
Other income     273100
Cost of revenue
(Cost of Product and Service Sold)		  (6,233)    
Gross profit:958,403173,900  273100
Operating expenses(1,258,500)(671,775)(380,496)(293,571)(242,482)(206,673)
Other undisclosed operating loss     (273)(100)
Operating loss:(300,097)(497,875)(380,496)(293,571)(242,482)(206,673)
Nonoperating income36,90146,65419,578   
Investment income, nonoperating37,36446,65419,578   
Interest and debt expense(25,088)(14,671)(12,712)(3,964)  
Loss from continuing operations:(288,284)(465,892)(373,630)(297,535)(242,482)(206,673)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(242,482)(206,673)
Other undisclosed net income    2,1856364,429
Net loss available to common stockholders, diluted:(288,284)(465,892)(373,630)(295,350)(241,846)(202,244)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(288,284)(465,892)(373,630)(295,350)(241,846)(202,244)
Comprehensive loss:(288,284)(465,892)(373,630)(295,350)(241,846)(202,244)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent405 50048(127)(169)
Comprehensive loss, net of tax, attributable to parent:(287,879)(465,892)(373,130)(295,302)(241,973)(202,413)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: